ORSO, Francesca
 Distribuzione geografica
Continente #
EU - Europa 5.248
NA - Nord America 1.527
AS - Asia 1.370
SA - Sud America 155
AF - Africa 121
Continente sconosciuto - Info sul continente non disponibili 69
OC - Oceania 1
Totale 8.491
Nazione #
NL - Olanda 3.752
US - Stati Uniti d'America 1.463
RU - Federazione Russa 572
SG - Singapore 530
IE - Irlanda 279
CN - Cina 256
IT - Italia 216
HK - Hong Kong 200
VN - Vietnam 163
DE - Germania 155
BR - Brasile 113
BJ - Benin 92
FR - Francia 81
KR - Corea 55
BD - Bangladesh 42
ID - Indonesia 40
SE - Svezia 37
GB - Regno Unito 34
CA - Canada 29
FI - Finlandia 25
IN - India 21
AT - Austria 19
MX - Messico 19
PL - Polonia 18
UA - Ucraina 18
JP - Giappone 15
AR - Argentina 14
ES - Italia 12
IQ - Iraq 11
LT - Lituania 9
BE - Belgio 7
CL - Cile 7
TR - Turchia 7
ZA - Sudafrica 7
EG - Egitto 6
AE - Emirati Arabi Uniti 5
EC - Ecuador 5
PH - Filippine 5
PK - Pakistan 5
CH - Svizzera 4
CR - Costa Rica 4
MA - Marocco 4
UY - Uruguay 4
CZ - Repubblica Ceca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
KE - Kenya 3
NP - Nepal 3
PY - Paraguay 3
VE - Venezuela 3
AL - Albania 2
AZ - Azerbaigian 2
BO - Bolivia 2
CO - Colombia 2
JM - Giamaica 2
NI - Nicaragua 2
PE - Perù 2
PT - Portogallo 2
SA - Arabia Saudita 2
TN - Tunisia 2
AO - Angola 1
BH - Bahrain 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
HN - Honduras 1
IL - Israele 1
JO - Giordania 1
LB - Libano 1
LV - Lettonia 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
PR - Porto Rico 1
PW - Palau 1
SN - Senegal 1
TC - Turks e Caicos 1
TG - Togo 1
TH - Thailandia 1
TT - Trinidad e Tobago 1
UZ - Uzbekistan 1
Totale 8.422
Città #
Amsterdam 3.745
Dublin 279
Council Bluffs 237
Hong Kong 199
San Jose 199
Singapore 189
Ashburn 137
Beijing 113
Columbus 92
Cotonou 92
Los Angeles 68
Moscow 64
Lauterbourg 56
Seoul 54
Mülheim 49
Ho Chi Minh City 48
Buffalo 43
Santa Clara 38
New York 37
Jakarta 35
Hanoi 28
Turin 26
Falkenstein 22
Helsinki 21
Dallas 19
Jacksonville 19
Warsaw 18
Novara 17
Dong Ket 16
Milan 15
Phoenix 15
Brooklyn 14
Nuremberg 14
Tokyo 14
Mexico City 13
Montreal 13
Denver 12
São Paulo 12
Bremen 11
Chennai 11
Frankfurt am Main 11
Munich 11
Orem 11
Vercelli 11
Dearborn 10
Atlanta 9
Da Nang 9
London 9
Rome 9
St Louis 9
Tianjin 9
Boardman 8
Piemonte 8
Houston 7
Assago 6
Baghdad 6
Brussels 6
Chicago 6
Haiphong 6
Stockholm 6
Toronto 6
Boston 5
Guangzhou 5
Lawrence 5
Naples 5
San Francisco 5
Vienna 5
Guayaquil 4
Kansas City 4
Montevideo 4
Poplar 4
Princeton 4
Ankara 3
Bauru 3
Belo Horizonte 3
Bắc Ninh 3
Cairo 3
Florence 3
Goiânia 3
Guarujá 3
Hangzhou 3
Hillsboro 3
Istanbul 3
Johannesburg 3
Manchester 3
Milwaukee 3
Ottawa 3
Philadelphia 3
Ribeirão Preto 3
Rio de Janeiro 3
San Mauro Torinese 3
Shanghai 3
Trieste 3
Wilmington 3
Andover 2
Arese 2
Asunción 2
Baku 2
Balneário Camboriú 2
Bari 2
Totale 6.405
Nome #
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.981
RICTOR/mTORC2 downregulation in BRAFV600E melanoma cells promotes resistance to BRAF/MEK inhibition 1.978
VEGF blockade enhances the antitumor effect of BRAFV600E inhibition 134
Identification of functional TFAP2A and SP1 binding sites in new TFAP2A-modulated genes 118
Axl-148b chimeric aptamers inhibit breast cancer and melanoma progression 107
Stroma-derived miR-214 coordinates tumor dissemination 95
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 92
Mir-214 and mir-148b targeting inhibits dissemination of melanoma and breast cancer 91
TCR gene transfer with lentiviral vectors allows efficient redirection of tumor specificity in naïve and memory T-cells without prior stimulation of endogenous TCR 90
ESDN inhibits melanoma progression by blocking E-selectin expression in endothelial cells via STAT3 89
Dysregulation of Blimp1 transcriptional repressor unleashes p130Cas/ErbB2 breast cancer invasion 87
Expression of AP-2a, AP-2g and ESDN in primary melanomas: Correlation with histopathological features and potential prognostic value 86
Antitumoral effects of attenuated Listeria monocytogenes in a genetically engineered mouse model of melanoma 85
Emerging roles of 3D-culture systems in tackling tumor drug resistance 77
miR-223 is a coordinator of breast cancer progression as revealed by bioinformatics predictions 76
Macrophage miR-210 induction and metabolic reprogramming in response to pathogen interaction boost life-threatening inflammation 76
AGO2 promotes telomerase activity and interaction between the telomerase components TERT and TERC 74
Identification of p130Cas/ErbB2-dependent invasive signatures in transformed mammary epithelial cells 73
Analysis of the regulatory regions of AP-2alpha-modulated genes selected for oral presentation and winner of the "Premio Chiara D'Onofrio Giovani Riercatori 2009" 73
MicroRNAs in metabolism for precision treatment of lung cancer 72
The chimeric aptamer axl-miR-214sponge inhibits breast cancer and melanoma dissemination 72
AP-2{alpha} and AP-2{gamma} regulate tumor progression via specific genetic programs 71
Dihydroorotate dehydrogenase inhibition reveals metabolic vulnerability in chronic myeloid leukemia 71
miR148b is a major coordinator of breast cancer progression in a relapse-associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS and CSF1 71
Therapeutic Silencing of miR-214 Inhibits Tumor Progression in Multiple Mouse Models 70
MiR-146a exerts differential effects on melanoma growth and metastatization 70
AP-2alpha regulates migration of GN-11 neurons via a specific genetic programme involving the Axl receptor tyrosine kinase 69
Do predicted microRNAs control gene networks involved in breast cancer progression? 69
miR-15a targets the HSP90 co-chaperone Morgana in chronic myeloid leukemia 68
DIFFERENTIAL REGULATION OF AP-2 GENES BY ESTROGEN IN HUMAN BREAST CANCER CELLS 68
The power of microRNAs as diagnostic and prognostic biomarkers in liquid biopsies 68
Role of coactivators and corepressors in steroid and nuclear receptor signaling: potential markers of tumor growth and drug sensitivity 68
Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region 67
The RNA-binding protein ESRP1 promotes human colorectal cancer progression 67
A computational pipeline to identify new potential regulatory motifs in melanoma progression. 66
The Ap-Alpha transcription factor regulates tumor cell migration 65
MicroRNA-Mediated Metabolic Shaping of the Tumor Microenvironment 65
microRNA-214 contributes to melanoma tumor progression through suppression of TFAP2C 65
mTORC1/autophagy-regulated MerTK in mutant BRAFV600 melanoma with acquired resistance to BRAF inhibition 65
microRNA-222 controls neovascularization by regulating signal transducer and activator of transcription 5A expression 65
microRNAs converge on the transcription factor FOXP2 and promote breast cancer metastasis 64
Interference with Activator Protein-2 transcription factors leads to induction of apoptosis and an increase in chemo- and radiation- sensitivity in breast cancer cells 64
miR-148b is a major coordinator in a Relapse-associated miR signature in Breast Tumors 64
DIFFERENTIAL REGULATION OF AP-2 TRANSCRIPTION FACTOR GENE EXPRESSION BY ESTROGEN IN HUMAN BREAST CANCER CELLS 63
ACTIVATOR PROTEIN-2 ALPHA TRANSCRIPTION FACTOR ROLES IN NEURONS 63
microRNA and cancer progression in Breast Tumours 63
CyTRANSFINDER: A Cytoscape 3.3 plugin for three-component (TF, gene, miRNA) signal transduction pathway construction 61
The role of melatonin on miRNAs modulation in triple-negative breast cancer cells 61
3-phosphoinositide-dependent kinase 1 controls breast tumor growth in a kinase-dependent but Akt-independent manner 61
miR-135b coordinates progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2 61
miR-214 as a Key Hub that Controls Cancer Networks: Small Player, Multiple Functions 61
Formation of STAT5/PPAR{gamma} Transcriptional Complex Modulates Angiogenic Cell Bioavailability in Diabetes 60
Role of miRNAs in tumor and endothelial cell interactions during tumor progression 60
miR-21 coordinates tumor growth and modulates KRIT1 levels 59
miR-214 coordinates melanoma progression by upregulating ALCAM through TFAP2 and miR-148b downmodulation 58
Do predicted microRNAs control gene networks involved in breast cancer progression? 58
Co-localization of AP2alpha transcription factor and TH-immunoreactive neurons in mouse locus coeruleus 55
High IGFBP2 expression correlates with tumor severity in pediatric rhabdomyosarcoma 54
Investigating the epi-miRNome: Identification of epi-miRNAs using transfection experiments 53
p130Cas/Cyclooxygenase-2 axis in the control of mesenchymal plasticity of breast cancer cells 52
miRNA-guided reprogramming of glucose and glutamine metabolism and its impact on cell adhesion/migration during solid tumor progression 51
POSSIBLE OESTROGENIC EFFECTS ON AP-2 ALPHA EXPRESSION AND AP-2 ALPHA POTENTIAL ROLE IN nNOS REGULATION IN MOUSE HYPOTHALAMUS 50
Identification of new AP-2alpha regulated genes: a biological and bioinformatic approach 47
PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p 47
Identification and characterization of microRNAs involved in tumor progression and metastasis 45
The AP-2alpha and AP-2gamma transcription factors regulate tumor progression and cell movement via specific genetic programs 40
The AP-2alpha and AP-2gamma transcription factors regulate tumor formation 40
null 23
Mitochondrial IκBα fuels cancer progression through metabolic rewiring, endothelial activation, and thrombotic spread 22
Transcriptome changes in circulating immune cells of critical COVID-19 patients predict a specific metabolic and epigenetic imprint 10
The promising regenerative potential of pulsed electromagnetic fields toward tendon differentiation 7
Totale 8.491
Categoria #
all - tutte 31.540
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 31.540


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/202220 0 2 0 4 1 0 2 0 3 1 1 6
2022/2023426 6 2 2 1 11 24 3 31 249 36 58 3
2023/2024284 17 18 40 17 61 3 42 7 3 2 25 49
2024/2025943 18 3 131 6 31 31 122 67 222 98 46 168
2025/20266.400 123 132 177 275 327 233 339 404 3.881 286 139 84
2026/2027320 122 198 0 0 0 0 0 0 0 0 0 0
Totale 8.491